Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Antimicrobial Chemotherapy

Antimicrobial Chemotherapy

Fr. 149.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

05.07.2015

Verlag

Oxford University Press

Seitenzahl

430

Maße (L/B/H)

24.6/16.9/2.5 cm

Gewicht

737 g

Auflage

7th Revised edition

Sprache

Englisch

ISBN

978-0-19-968977-4

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

05.07.2015

Verlag

Oxford University Press

Seitenzahl

430

Maße (L/B/H)

24.6/16.9/2.5 cm

Gewicht

737 g

Auflage

7th Revised edition

Sprache

Englisch

ISBN

978-0-19-968977-4

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Antimicrobial Chemotherapy

    • Part 1: General properties of antimicrobial agents

    • 1: Mechanisms of action and resistance to modern antibacterial with a history of their development

    • 2: Inhibitors of bacterial cell wall synthesis

    • 3: Inhibitors of bacterial protein synthesis

    • 4: Synthetic antibacterial agents and miscellaneous antibiotics

    • 5: Antiviral agents

    • 6: Antiretroviral agents

    • 7: Drugs used in the treatment of viral hepatitis

    • 8: Antifungal agents

    • 9: Antiprotozoal and anthelminthic agents

    • Part 2: Resistance to antimicrobial agents

    • 10: The problem of resistance

    • 11: The genetics and mechanisms of acquired resistance

    • Part 3: General principles of usage of antimicrobial agents

    • 12: Laboratory investigations and the treatment of infection

    • 13: General principles of the treatment of infection

    • 14: Pharmacokinetic and pharmacodynamics principles

    • 15: Prescribing in special groups: effects of age, pregnancy, body weight, hepatic and renal impairment

    • 16: Outpatient parenteral antimicrobial therapy

    • 17: Adverse drug reactions and patient safety

    • 18: Chemoprophylaxis and immunisation

    • 19: Guidelines, formularies, and antimicrobial policies

    • 20: Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences

    • Part 4: Therapeutic use of antimicrobial agents

    • 21: Respiratory tract infections

    • 22: Topical use of antimicrobial agents

    • 23: Urinary tract infections

    • 24: Sexually transmitted infections

    • 25: Gastrointestinal infections

    • 26: Serious bacterial bloodstream infections

    • 27: Bone and joint infections

    • 28: Infections of the central nervous system

    • 29: Skin and soft tissue infections

    • 30: Tuberculosis and other mycobacterial diseases

    • 31: Infections in immunocompromised patients including HIV/AIDs

    • 32: Viral infections

    • 33: Management of HIV infection

    • 34: Treatment of chronic viral hepatitis

    • 35: Parasitic disease

    • 36: The development and marketing of antimicrobial drugs

    • Appendix 1: Further Reading